Caption Christine Proctor - participant in the GDNF trial Why we’re committing £800,000 to plan a new GDNF trial Date 23 February 2021
New research on levodopa's influence on Parkinson's progression Date 30 January 2019 A clinical trial has produced further evidence that there is no benefit of delaying levodopa therapy.
Steps towards new drugs to improve symptoms and slow Parkinson’s Date 30 January 2019 We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.
Scientists use gene editing to create 'tougher' stem cells Date 20 December 2018 Researchers at the University of Edinburgh have used cutting-edge gene-editing techniques to create stem cells that are resistant to developing Parkinson’s.
We're changing the way we review our project grant applications Date 18 December 2018 We're streamlining and speeding up our project grant review process.
Experimental cancer drug shows promise for Parkinson's Date 29 November 2018 A drug originally developed for prostate cancer may have exciting potential for treating Parkinson's, according to research published today in Cell Stem Cell.
People who smoke may be less likely to develop Parkinson's Date 20 November 2018 European study suggests that smoking has a protective role to reduce the risk of developing Parkinson's.
Stopping the build-up of toxic proteins in Parkinson's Date 15 November 2018 Scientists have identified a key molecule - called USP13 - which may provide a new avenue to prevent the build up of alpha-synuclein in brain cells.
Research points to the appendix being the source of Parkinson's Date 31 October 2018 Results published today in the scientific journal Science Translational Medicine highlights a link between the removal of the appendix and a reduced risk of developing Parkinson's.
10,000 people without Parkinson's needed for online study Date 24 October 2018 The UK-wide Predict PD study, funded by Parkinson's UK, is seeking 10,000 people aged 60-80 without Parkinson's to find clues to the very earliest stages of the condition.
Promising early results for potential new treatment for Parkinson's Date 11 October 2018 The pharmaceutical company Biogen has presented promising initial results from trials testing a potential new treatment for Parkinson's which targets the alpha-synuclein protein.
